Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: A potential improvement of intravesical chemotherapy in bladder cancer

Bioelectrochemistry

Volumn 88, Issue , 2012, Pages 127-133

  Vásquez, Juan L ^a,b,c   Gehl, Julie ^a   Hermann, Gregers G ^b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Bladder cancer cell lines; Electroporation; EMDA; Mitomycin C; T24

Indexed keywords

BLADDER CANCER CELL LINE; ELECTROPORATION; EMDA; MITOMYCIN C; T24;

CELL MEMBRANES; CHEMOTHERAPY; DISEASES; PATIENT TREATMENT;

CELL CULTURE;

BLEOMYCIN; MITOMYCIN C;

ANIMAL CELL; ARTICLE; BLADDER CANCER; CELL SURVIVAL; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ELECTROPORATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PH;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; BLEOMYCIN; CELL LINE, TUMOR; CRICETINAE; ELECTROPORATION; HUMANS; MITOMYCIN; QUALITY OF LIFE; URINARY BLADDER NEOPLASMS;

CRICETULUS GRISEUS;

EID: 84865503161     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2012.08.001     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003, 21:1315-1330.
3. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Bohle A., Palou-Redorta J., Roupret M. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur. Urol. 2011, 59:997-1008.
4. Brausi M., Witjes J.A., Lamm D., Persad R., Palou J., Colombel M., Buckley R., Soloway M., Akaza H., Bohle A. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J. Urol. 2011, 186:2158-2167.
5. Herr H.W. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. Semin. Urol. Oncol. 1997, 15:142-146.
6. Nieder A.M., Brausi M., Lamm D., O'Donnell M., Tomita K., Woo H., Jewett M.A. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology 2005, 66:108-125.
7. Amling C.L., Thrasher J.B., Frazier H.A., Dodge R.K., Robertson J.E., Paulson D.F. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J. Urol. 1994, 151:31-35.
8. Ghoneim M.A., El-Mekresh M.M., El-Baz M.A., El-Attar I.A., Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J. Urol. 1997, 158:393-399.
9. Hermann G.G., Mogensen K., Carlsson S., Marcussen N., Duun S. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int. 2011, 108:E297-E303.
10. Herr H.W., Donat S.M. Quality control in transurethral resection of bladder tumours. BJU Int. 2008, 102:1242-1246.
11. Klan R., Loy V., Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J. Urol. 1991, 146:316-318.
12. Solsona E., Iborra I., Ricos J.V., Monros J.L., Casanova J., Dumont R. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup. J. Urol. 1999, 161:1120-1123.
13. Au J.L., Badalament R.A., Wientjes M.G., Young D.C., Warner J.A., Venema P.L., Pollifrone D.L., Harbrecht J.D., Chin J.L., Lerner S.P., Miles B.J. Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J. Natl. Cancer Inst. 2001, 93:597-604.
14. Maeda T., Kikuchi E., Matsumoto K., Miyajima A., Oya M. Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor. J. Urol. 2011, 185:802-806.
15. Di Stasi S.M., Giannantoni A., Massoud R., Dolci S., Navarra P., Vespasiani G., Stephen R.L. Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies. Cancer Res. 1999, 59:4912-4918.
16. Riedl C.R., Knoll M., Plas E., Pfluger H. Intravesical electromotive drug administration technique: preliminary results and side effects. J. Urol. 1998, 159:1851-1856.
17. Di Stasi S.M., Giannantoni A., Stephen R.L., Capelli G., Navarra P., Massoud R., Vespasiani G. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J. Urol. 2003, 170:777-782.
18. Di Stasi S.M., Riedl C. Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. World J. Urol. 2009, 27:325-330.
19. Giannantoni A., Di Stasi S.M., Chancellor M.B., Costantini E., Porena M. New frontiers in intravesical therapies and drug delivery. Eur. Urol. 2006, 50:1183-1193.
20. Kee S., Gehl J., Lee E.W. Clinical Aspects of Electroporation 2011, Springer, New York.
21. Matthiessen L.W., Johannesen H.H., Hendel H.W., Moss T., Kamby C., Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012, 51:713-721.
22. Marty M., Sersa G., Garbay J.R., Gehl J., Collins C.G., Snoj M., Billard V., Geertsen P.F., Larkin J.O., Miklavcic D., Pavlovic I., Paulin-Kosir S.M., Cemazar M., Morsli N., Rudolf Z., Robert C., O'Sullivan G.C., Mir L.M. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006, 4:3-13.
23. Sersa G., Miklavcic D., Cemazar M., Rudolf Z., Pucihar G., Snoj M. Electrochemotherapy in treatment of tumours. Eur. J. Surg. Oncol. 2008, 34:232-240.
24. Kubota Y., Mir L.M., Nakada T., Sasagawa I., Suzuki H., Aoyama N. Successful treatment of metastatic skin lesions with electrochemotherapy. J. Urol. 1998, 160:1426.
25. Agerholm-Larsen B., Iversen H.K., Ibsen P., Moller J.M., Mahmood F., Jensen K.S., Gehl J. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res. 2011, 71:3753-3762.
26. Edhemovic I., Gadzijev E.M., Brecelj E., Miklavcic D., Kos B., Zupanic A., Mali B., Jarm T., Pavliha D., Marcan M., Gasljevic G., Gorjup V., Music M., Vavpotic T.P., Cemazar M., Snoj M., Sersa G. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol. Cancer Res. Treat. 2011, 10:475-485.
27. Panje W.R., Sadeghi N. Endoscopic and electroporation therapy of paranasal sinus tumors. Am. J. Rhinol. 2000, 14:187-191.
28. Soden D.M., Larkin J.O., Collins C.G., Tangney M., Aarons S., Piggott J., Morrissey A., Dunne C., O'Sullivan G.C. Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett. 2006, 232:300-310.
29. Kuriyama S., Tsujinoue H., Toyokawa Y., Mitoro A., Nakatani T., Yoshiji H., Tsujimoto T., Fukui H. A potential approach for electrochemotherapy against colorectal carcinoma using a clinically available alternating current system with bipolar snare in a mouse model. Scand. J. Gastroenterol. 2001, 36:297-302.
30. Bubenik J., Baresova M., Viklicky V., Jakoubkova J., Sainerova H., Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int. J. Cancer 1973, 11:765-773.
31. Gehl J., Skovsgaard T., Mir L.M. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998, 9:319-325.
32. Frandsen S.K., Gissel H., Hojman P., Tramm T., Eriksen J., Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012, 72:1336-1341.
33. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
34. Oshima Y., Sakamoto T., Sonoda K., Yoshida H., Ishibashi T., Inomata H. Effect of electric pulses and antiproliferative drugs on cultured bovine retinal pigment epithelial cells. Curr. Eye Res. 1997, 16:64-70.
35. Nanda G.S., Sun F.X., Hofmann G.A., Hoffman R.M., Dev S.B. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. Anticancer Res. 1998, 18:1361-1366.
36. Joergensen M., Agerholm-Larsen B., Nielsen P.E., Gehl J. Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry. Oligonucleotides 2011, 21:29-37.